Diagnamed Holdings Corp. (DMED.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -100.27 Thousand CAD | 91.2% |
| 2022 | - CAD | -296.21% |
| 2021 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -270.57 Thousand CAD | -417.63% |
| 2024 Q3 | -167.04 Thousand CAD | -33.61% |
| 2024 Q1 | -155.15 Thousand CAD | 0.0% |
| 2023 FY | - CAD | -10.01% |
| 2023 Q4 | -164.13 Thousand CAD | 29.0% |
| 2023 Q3 | -231.16 Thousand CAD | 50.04% |
| 2023 Q2 | -462.69 Thousand CAD | -26.96% |
| 2023 Q1 | -364.43 Thousand CAD | -18.33% |
| 2022 FY | - CAD | -296.21% |
| 2022 Q3 | -328.8 Thousand CAD | -0.8% |
| 2022 Q2 | -326.18 Thousand CAD | -88.82% |
| 2022 Q4 | -307.97 Thousand CAD | 6.34% |
| 2022 Q1 | -172.74 Thousand CAD | 15.14% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | -203.56 Thousand CAD | 40.4% |
| 2021 Q3 | -341.52 Thousand CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AI/ML Innovations Inc. | -1.66 Million CAD | 93.977% |
| Pangenomic Health Inc. | -2.71 Million CAD | 96.302% |
| nDatalyze Corp. | -290.5 Thousand CAD | 65.483% |
| Treatment.Com International Inc. | -3.64 Million CAD | 97.25% |
| Unidoc Health Corp. | -2.18 Million CAD | 95.407% |